Ronald Spillane MD in Rockville Centre, New York

Home New York Rockville Centre

Ronald Spillane MD has Dermatology as his primary medical specialty. Their primary office is: 45 Roxen Rd in Rockville Centre, New York. There are 2 additional office locations for Ronald Spillane MD that can be viewed towards the end of their profile. They attended Georgetown University School Of Medicine and graduated in 1977 (around 47 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ronald E Spillane MD Office Phone and Directions

Ronald Spillane MD
45 Roxen Rd
Rockville Centre, New York 11570
516-678-0048

Patient Ratings
Please rate your experience with Ronald Spillane MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 516-678-0048

Enter a starting address:

Healthcare Info for Ronald Spillane MD

Medical School: Georgetown University School Of Medicine
Graduation Year: 1977
The Primary Medical Specialty for Ronald Spillane MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 47
PAC (PECOS ID)#: 5698784718
NPI #: 1295706992
NPI Created On: 01/30/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207N00000X
License Number:
135394
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Shaving of 1.1 to 2.0 centimeters skin growth of the trunk, arms, or legs
Injection of up to 7 skin growths
Injection of more than 7 skin growths
Destruction of skin growth
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of 2-14 skin growths
Destruction of 15 or more skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (2.1 to 3.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788083975

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01